He, Wei
McCoy, Matthew D.
Riggins, Rebecca B.
Beckman, Robert A.
Yeang, Chen-Hsiang
Funding for this research was provided by:
Department of Defense Breast Cancer Research Program Awards (W81XWH-20-1-0759 and W81XWH-20-1-0760)
Department of Defense Breast Cancer Research Program Awards (W81XWH-20-1-0759 and W81XWH-20-1-0760)
Department of Defense Breast Cancer Research Program Awards (W81XWH-20-1-0759 and W81XWH-20-1-0760)
Department of Defense Breast Cancer Research Program Awards (W81XWH-20-1-0759 and W81XWH-20-1-0760)
National Science Foundation grants (#2138259, #2138286, #2138307, #2137603, and #2138296)
National Science Foundation grants (#2138259, #2138286, #2138307, #2137603, and #2138296)
National Science & Technology Council in the Republic of China (108-2118-M-001-001-MY2)
Article History
Received: 11 November 2024
Accepted: 8 June 2025
First Online: 3 July 2025
Competing interests
: R.A.B. is the Chief Scientific Officer of Onco-Mind, LLC, which owns patents on DPM in the European Union, Taiwan, and Japan. R.A.B. is uncompensated in this role and receives no royalties from these patents. All other authors declare no competing interests.